Author:
Enomoto Takehiko,Kanda Tatsuo,Yajima Kazuhito,Hirota Seiichi,Matsuki Atsushi,Kosugi Shin-ichi,Kato Takashi,Ajioka Yoichi,Hatakeyama Katsuyoshi
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Reference15 articles.
1. Miettinen M, Laseta J. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics. Pol J Pathol. 2003;54:3–24.
2. Demetri GD, Mehren M, Blanke CD, Abbeele AD, Eisenberg B, Roberts PJ, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002;347:472–80.
3. van Oosterom AT, Judson I, Verweij J, Stroobants S, Donato di Paola E, Dimitrijevic S, et al. European Organisation for Research and Treatment of Cancer. Soft Tissue and Bone Sarcoma Group. Lancet. 2001;358:1421–3.
4. Oku T, Waga E, Sumiyoshi T, Yoshizaki N, Kondo H, Ohira N, et al. A case of primary small intestinal gastrointestinal stromal tumor: an intraperitoneal bleeding from greater omentum metastasis caused by administration of imatinib mesylate. Nippon Shokakibyo Gakkai Zassi (JJSG). 2003;100:863–7. (in Japanese with English abstract).
5. Hirasaki S, Fujita K, Matsubara M, Kanzaki H, Yamane H, Okuda M, et al. A ruptured large extraluminal ileal gastro-intestinal stromal tumor causing hemoperitoneum. World J Gastroenterol. 2008;14:2928–31.